_id

691310b9ccc777a4e85d7e94

Ticker

LSB

Name

LakeShore Biopharma Co., Ltd

Exchange

NASDAQ

Address

Building No. 2, Beijing, China, 102629

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.lakeshorebio.com

Description

LakeShore Biopharma Co., Ltd, a biopharmaceutical company, discovers, develops, manufactures, commercializes, and sells vaccines and therapeutic biologics for infectious diseases and cancer. Its product pipeline includes YSJA, a conventional rabies vaccine, which is in marketed stage; PIKA, a rabies vaccine, which is in phase I/III and preclinical trials for the treatment of rabies virus; PIKA YS-ON-001, an immuno-oncology therapeutic candidate that is in phase I trial for the treatment of pancreatic and hepatocellular cancer; PIKA YS-HBV-001, a hepatitis B vaccine, which is in phase I trial; PIKA YS-HBV-002, an immune-therapy vaccine that is in preclinical trial for the treatment of chronic HBV infection; and PIKA YS-ON-001 and PIKA Influenza Vaccine, which are in preclinical trials. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 1994 and is based in Beijing, China.

Last Close

0.627

Volume

8912

Current Price

0.627

Change

0

Last Updated

2025-11-22T17:16:08.156Z

Image

data:image/webp;base64,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

Ipo Date

2023-03-16T00:00:00.000Z

Market Cap

25840356

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Rating

5

Target Price

4.19

Strong Buy

1

Buy

0

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2024-06-30

Revenue

135527333

Cost Of Revenue

101119004

Gross Profit

34408329

Operating Expenses

215553846

Operating Income

-181145517

Interest Expense

23635947

Pretax Income

-194896565

Net Income

-181410236

Eps

-1.8142717948429203

Dividends Per Share

-

Shares Outstanding

99990661

Income Tax Expense

-13719098

EBITDA

-82617124

Operating Margin

-133.6597666243458

Total Other Income Expense Net

-13751048

Cash

246351231

Short Term Investments

-

Receivables

444161291

Inventories

205085341

Total Current Assets

903167952

Property Plant Equipment

480623373

Total Assets

1513027356

Payables

67774798

Short Term Debt

323697272

Long Term Debt

-

Total Liabilities

927821054

Equity

585206302

Depreciation

10546346

Change In Working Capital

-

Cash From Operations

-

Capital Expenditures

0

Cash From Investing

-

Cash From Financing

-

Net Change In Cash

-

PE

-

PB

0.10713169737362124

ROE

-30.99936473343037

ROA

-11.989884735435014

FCF

-

Fcf Percent

-

Piotroski FScore

0

Health Score

31

Deep Value Investing Score

5

Defensive Investing Score

5.5

Dividend Investing Score

1.5

Economic Moat Investing Score

2.8

Garp Investing Score

1.5

Growth Investing Score

1

Momentum Investing Score

2.5

Net Net Investing Score

3.5

Quality Investing Score

1.5

Value Investing Score

4

Quarters > 0 > quarter

2024-06-30

Quarters > 0 > income Statement > revenue

135527333

Quarters > 0 > income Statement > cost Of Revenue

101119004

Quarters > 0 > income Statement > gross Profit

34408329

Quarters > 0 > income Statement > operating Expenses

215553846

Quarters > 0 > income Statement > operating Income

-181145517

Quarters > 0 > income Statement > interest Expense

23635947

Quarters > 0 > income Statement > pretax Income

-194896565

Quarters > 0 > income Statement > net Income

-181410236

Quarters > 0 > income Statement > eps

-1.8142717948429203

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

99990661

Quarters > 0 > income Statement > income Tax Expense

-13719098

Quarters > 0 > income Statement > EBITDA

-82617124

Quarters > 0 > income Statement > operating Margin

-133.6597666243458

Quarters > 0 > income Statement > total Other Income Expense Net

-13751048

Quarters > 0 > balance Sheet > cash

246351231

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

444161291

Quarters > 0 > balance Sheet > inventories

205085341

Quarters > 0 > balance Sheet > total Current Assets

903167952

Quarters > 0 > balance Sheet > property Plant Equipment

480623373

Quarters > 0 > balance Sheet > total Assets

1513027356

Quarters > 0 > balance Sheet > payables

67774798

Quarters > 0 > balance Sheet > short Term Debt

323697272

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

927821054

Quarters > 0 > balance Sheet > equity

585206302

Quarters > 0 > cash Flow > net Income

-181410236

Quarters > 0 > cash Flow > depreciation

10546346

Quarters > 0 > cash Flow > change In Working Capital

-

Quarters > 0 > cash Flow > cash From Operations

-

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

-

Quarters > 0 > cash Flow > net Change In Cash

-

Quarters > 0 > ratios > PE

-1.8142717948429203

Quarters > 0 > ratios > PB

0.10713169737362124

Quarters > 0 > ratios > ROE

-30.99936473343037

Quarters > 0 > ratios > ROA

-11.989884735435014

Quarters > 0 > ratios > FCF

-

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

31

Quarters > 1 > quarter

2024-03-31

Quarters > 1 > income Statement > revenue

135527333

Quarters > 1 > income Statement > cost Of Revenue

101119004

Quarters > 1 > income Statement > gross Profit

34408329

Quarters > 1 > income Statement > operating Expenses

215553846

Quarters > 1 > income Statement > operating Income

-181145517

Quarters > 1 > income Statement > interest Expense

23635947

Quarters > 1 > income Statement > pretax Income

-194896565

Quarters > 1 > income Statement > net Income

-181410236

Quarters > 1 > income Statement > eps

-1.8142717948429203

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

99990661

Quarters > 1 > income Statement > income Tax Expense

-13719098

Quarters > 1 > income Statement > EBITDA

-82617124

Quarters > 1 > income Statement > operating Margin

-133.6597666243458

Quarters > 1 > income Statement > total Other Income Expense Net

-13751048

Quarters > 1 > balance Sheet > cash

246351231

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

444161291

Quarters > 1 > balance Sheet > inventories

205085341

Quarters > 1 > balance Sheet > total Current Assets

903167952

Quarters > 1 > balance Sheet > property Plant Equipment

480623373

Quarters > 1 > balance Sheet > total Assets

1513027356

Quarters > 1 > balance Sheet > payables

67774798

Quarters > 1 > balance Sheet > short Term Debt

323697272

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

927821054

Quarters > 1 > balance Sheet > equity

585206302

Quarters > 1 > cash Flow > net Income

-181410236

Quarters > 1 > cash Flow > depreciation

10546346

Quarters > 1 > cash Flow > change In Working Capital

-

Quarters > 1 > cash Flow > cash From Operations

-

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-

Quarters > 1 > cash Flow > cash From Financing

-

Quarters > 1 > cash Flow > net Change In Cash

-

Quarters > 1 > ratios > PE

-1.8142717948429203

Quarters > 1 > ratios > PB

0.10713169737362124

Quarters > 1 > ratios > ROE

-30.99936473343037

Quarters > 1 > ratios > ROA

-11.989884735435014

Quarters > 1 > ratios > FCF

-

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

31

Quarters > 2 > quarter

2023-12-31

Quarters > 2 > income Statement > revenue

168705602

Quarters > 2 > income Statement > cost Of Revenue

34898919

Quarters > 2 > income Statement > gross Profit

133806682

Quarters > 2 > income Statement > operating Expenses

217964062

Quarters > 2 > income Statement > operating Income

-81428370

Quarters > 2 > income Statement > interest Expense

8352814

Quarters > 2 > income Statement > pretax Income

-84953762

Quarters > 2 > income Statement > net Income

-77770202

Quarters > 2 > income Statement > eps

-0.8357157348841907

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

93058200

Quarters > 2 > income Statement > income Tax Expense

-7189156

Quarters > 2 > income Statement > EBITDA

-72354211

Quarters > 2 > income Statement > operating Margin

-48.2665477818573

Quarters > 2 > income Statement > total Other Income Expense Net

-3525392

Quarters > 2 > balance Sheet > cash

222659449

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

403122000

Quarters > 2 > balance Sheet > inventories

190781127

Quarters > 2 > balance Sheet > total Current Assets

826767808

Quarters > 2 > balance Sheet > property Plant Equipment

568831000

Quarters > 2 > balance Sheet > total Assets

1510727820

Quarters > 2 > balance Sheet > payables

10924652

Quarters > 2 > balance Sheet > short Term Debt

428982000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

1035921000

Quarters > 2 > balance Sheet > equity

474604442

Quarters > 2 > cash Flow > net Income

-77619773

Quarters > 2 > cash Flow > depreciation

9154207

Quarters > 2 > cash Flow > change In Working Capital

-

Quarters > 2 > cash Flow > cash From Operations

-

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

-

Quarters > 2 > cash Flow > cash From Financing

-

Quarters > 2 > cash Flow > net Change In Cash

-

Quarters > 2 > ratios > PE

-0.8357157348841907

Quarters > 2 > ratios > PB

0.12293920207346057

Quarters > 2 > ratios > ROE

-16.386319873508473

Quarters > 2 > ratios > ROA

-5.147863233232839

Quarters > 2 > ratios > FCF

-

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

27

Quarters > 3 > quarter

2023-09-30

Quarters > 3 > income Statement > revenue

96818454

Quarters > 3 > income Statement > cost Of Revenue

17507142

Quarters > 3 > income Statement > gross Profit

79311312

Quarters > 3 > income Statement > operating Expenses

179362368

Quarters > 3 > income Statement > operating Income

-113204615

Quarters > 3 > income Statement > interest Expense

6898098

Quarters > 3 > income Statement > pretax Income

-105215151

Quarters > 3 > income Statement > net Income

-104980798

Quarters > 3 > income Statement > eps

-1.1281198366652214

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

93058197

Quarters > 3 > income Statement > income Tax Expense

-234353

Quarters > 3 > income Statement > EBITDA

-98475361

Quarters > 3 > income Statement > operating Margin

-116.92462575368121

Quarters > 3 > income Statement > total Other Income Expense Net

7989464

Quarters > 3 > balance Sheet > cash

259905532

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

429368934

Quarters > 3 > balance Sheet > inventories

212820371

Quarters > 3 > balance Sheet > total Current Assets

934605218

Quarters > 3 > balance Sheet > property Plant Equipment

571285599

Quarters > 3 > balance Sheet > total Assets

1611283104

Quarters > 3 > balance Sheet > payables

11639246

Quarters > 3 > balance Sheet > short Term Debt

30057361

Quarters > 3 > balance Sheet > long Term Debt

361965073

Quarters > 3 > balance Sheet > total Liabilities

1054186774

Quarters > 3 > balance Sheet > equity

557096330

Quarters > 3 > cash Flow > net Income

-105017700

Quarters > 3 > cash Flow > depreciation

14729254

Quarters > 3 > cash Flow > change In Working Capital

-

Quarters > 3 > cash Flow > cash From Operations

-

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

-

Quarters > 3 > cash Flow > cash From Financing

-

Quarters > 3 > cash Flow > net Change In Cash

-

Quarters > 3 > ratios > PE

-1.1281198366652214

Quarters > 3 > ratios > PB

0.10473500968674485

Quarters > 3 > ratios > ROE

-18.84428102407352

Quarters > 3 > ratios > ROA

-6.515353989586674

Quarters > 3 > ratios > FCF

-

Quarters > 3 > ratios > Piotroski FScore

0

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

31

Valuation > metrics > PE

-1.8142717948429203

Valuation > metrics > PB

0.10713169737362124

Valuation > final Score

70

Valuation > verdict

89.3% Undervalued

Profitability > metrics > ROE

-30.99936473343037

Profitability > metrics > ROA

-20.085991270868302

Profitability > metrics > Net Margin

-1.3385509179908381

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

1.5854597785927467

Risk > metrics > Interest Coverage

-7.663983888608313

Risk > final Score

-1

Risk > verdict

High

Liquidity > metrics > Current Ratio

2.3071069974417333

Liquidity > metrics > Quick Ratio

1.7832245631214507

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

70

Prev Valuations > 1

70

Prev Valuations > 2

70

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

-1

Prev Risks > 1

-21

Prev Risks > 2

-36

Prev Liquidities > 0

100

Prev Liquidities > 1

97

Prev Liquidities > 2

100

Updated At

2026-01-20T22:09:25.308Z